Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1021 AL 1035

Single amino acid and trinucleotide repeats: function and evolution

Faux N.

Adv Exp Med Biol. 2012;769:26-40. doi: 10.1007/978-1-4614-5434-2_3.

Dynamic mutations: where are they now?

van Eyk CL, Richards RI.

Adv Exp Med Biol. 2012;769:55-77.

Polyglutamine aggregation in Huntington and related diseases

Polling S, Hill AF, Hatters DM.

Adv Exp Med Biol. 2012;769:125-40. doi: 10.1007/978-1-4614-5434-2_8.

Selective neurodegeneration, neuropathology and symptom profiles in Huntington's disease

Waldvogel HJ, Thu D, Hogg V, Tippett L, Faull RL.

Adv Exp Med Biol. 2012;769:141-52. doi: 10.1007/978-1-4614-5434-2_9.

Age-Dependent Resistance to Excitotoxicity in Htt CAG140 Mice and the Effect of Strain Background

Strong MK, Southwell AL, Yonan JM, Hayden MR, Macgregor GR, Thompson LM, Steward O.

J Huntingtons Dis. 2012;1(2):221-41. doi: 10.3233/JHD-129005.

Treatment of segmental loss of the tibia by tibialisation of the fibula: a review of the literature

Rahimnia A, Fitoussi F, Penneçot G, Mazda K.

Trauma Mon. 2012 Jan;16(4):154-9. doi: 10.5812/kowsar.22517464.3184. Epub 2012 Jan 15.

Hypothalamic and Limbic System Changes in Huntington's Disease

Petersén A, Gabery S.

J Huntingtons Dis. 2012;1(1):5-16. doi: 10.3233/JHD-2012-120006.

Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease

Galvan L, André VM, Wang EA, Cepeda C, Levine MS.

J Huntingtons Dis. 2012;1(1):17-25. doi: 10.3233/JHD-2012-120009.

Neuroleptic Malignant Syndrome Induced by Olanzapine in a Patient with Huntington's Disease

Moreno JL, Palau Fayos JM, Díaz de Santiago A, García de Yébenes J.

J Huntingtons Dis. 2012;1(1):31-2. doi: 10.3233/JHD-2012-120008.

Plasma 8-hydroxy-2'-deoxyguanosine Levels in Huntington Disease and Healthy Controls Treated with Coenzyme Q10

Biglan KM, Dorsey ER, Evans RV, Ross CA, Hersch S, Shoulson I, Matson W, Kieburtz K; Huntington Study Group Pre-2CARE Investigators.

J Huntingtons Dis. 2012;1(1):65-9. doi: 10.3233/JHD-2012-120007.

Eugenics, Heredity, and Huntington's Disease: A Brief Historical Perspective

Wexler A.

J Huntingtons Dis. 2012;1(2):139-41. doi: 10.3233/JHD-129007.

Cognitive Dysfunction in Huntington's Disease: Humans, Mouse Models and Molecular Mechanisms

Giralt A, Saavedra A, Alberch J, Pérez-Navarro E.

J Huntingtons Dis. 2012;1(2):155-73. doi: 10.3233/JHD-120023.

Practice, progress and future directions for physical therapies in Huntingtons disease

Busse M, Khalil H, Brooks S, Quinn L, Rosser A.

J Huntingtons Dis. 2012;1(2):175-85. doi: 10.3233/JHD-120025.

Benign hereditary chorea 2: pathological findings in an autopsy case

Yoshida Y, Nunomura J, Shimohata T, Nanjo H, Miyata H.

Neuropathology. 2012 Oct;32(5):557-65. doi: 10.1111/j.1440-1789.2011.01288.x. Epub 2012 Jan 12.

Dextromethorphan/quinidine for chorea: an open-label assessment

Ondo WG.

Clin Neuropharmacol. 2012 Jan-Feb;35(1):53-4. doi: 10.1097/WNF.0b013e31823d78c4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias